Correlation of EBV-specific T cells with EBV viral load in high-risk stem cell and solid organ allograft recipients
Patient . | Recipient HLA type . | Allograft, type (day following transplant) . | EBV genomes, 105PBMCs . | EBV-specific T cells, % . | |||
---|---|---|---|---|---|---|---|
A2 . | B7 . | B8R . | B8F . | ||||
YS-1 | A1,—; B8,37 | renal (D240) | <5 | — | — | 0 | 0.5 |
YS-2 | A1,2; B8,44 | renal (D210) | <5 | 0.4 | — | 0.1 | 0.9 |
YS-3 | A1,2; B8,18 | renal (D220) | <5 | 0.2 | — | 0.6 | 0.3 |
YS-4 | A30,31; B8,35 | renal (D330) | <5 | — | — | 0.4 | 0.3 |
YS-5 | A1,26; B8,35 | renal (D450)3-150 | 371 | — | — | 0 | 0 |
M-1 | A2,30; B35,70 | UCB (D60) | <5 | 0 | — | — | — |
M-2 | A3; B7,40 | UCB (D60) | <5 | — | 0 | — | — |
M-3 | A2; B18,57 | UCB (D180) | <5 | 0 | — | — | — |
M-4 | A24; B7,56 | MUD (D28) | 176 | — | 0 | — | — |
M-5 | A2,32; B15 | UCB (D90) | <5 | 0 | — | — | — |
F | A2,23; B49,60 | HAPLO (D180) | <5 | 0 | — | — | — |
Patient . | Recipient HLA type . | Allograft, type (day following transplant) . | EBV genomes, 105PBMCs . | EBV-specific T cells, % . | |||
---|---|---|---|---|---|---|---|
A2 . | B7 . | B8R . | B8F . | ||||
YS-1 | A1,—; B8,37 | renal (D240) | <5 | — | — | 0 | 0.5 |
YS-2 | A1,2; B8,44 | renal (D210) | <5 | 0.4 | — | 0.1 | 0.9 |
YS-3 | A1,2; B8,18 | renal (D220) | <5 | 0.2 | — | 0.6 | 0.3 |
YS-4 | A30,31; B8,35 | renal (D330) | <5 | — | — | 0.4 | 0.3 |
YS-5 | A1,26; B8,35 | renal (D450)3-150 | 371 | — | — | 0 | 0 |
M-1 | A2,30; B35,70 | UCB (D60) | <5 | 0 | — | — | — |
M-2 | A3; B7,40 | UCB (D60) | <5 | — | 0 | — | — |
M-3 | A2; B18,57 | UCB (D180) | <5 | 0 | — | — | — |
M-4 | A24; B7,56 | MUD (D28) | 176 | — | 0 | — | — |
M-5 | A2,32; B15 | UCB (D90) | <5 | 0 | — | — | — |
F | A2,23; B49,60 | HAPLO (D180) | <5 | 0 | — | — | — |
The following tetramers were used in this table: A indicates A2-GLC-lytic; B7, B7-RPP-latent; B8R, B8-RAK-lytic; and B8F, B8-FLR-latent.
Denotes that the patient underwent a renal and pancreas transplantation.